Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by steadfaston Apr 06, 2015 3:57pm

92 Views

Post# 23601529

RE:RE:RE:RE:Another point to raise at AGM

Donkeyfeathers:
I understood we are waiting to learn the efficacy data on human patients - NOT animals.
Dr. White stated on Sept 26, 2013
The findings in these initial patients parallel the results in Sernova's small and large
animal safety and efficacy studies of the Cell Pouch.

Dr. T refers in 2012 Ahead of the Herd Newsletter
page 5 of 7 When there is a clear efficacy data in a number of patients, we will be
able to release those data.

Please clarify. Thank you in advance.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"